Biocept, Inc. filed a voluntary petition liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware on October 13, 2023. The debtor listed its assets of $2.49 million and liabilities of $2.92 million. The debtor is represented by Matthew P. Ward of Womble Bond Dickinson (US) LLP as its legal counsel.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | -99.76% |
Apr. 02 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
2023 | Biocept, Inc.(OTCPK:BIOC.Q) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-99.76% | 262 | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- BIOCQ Stock
- News Biocept, Inc.
- Biocept, Inc. Filed for Bankruptcy